Cognitive decline in Parkinson's disease: a prospective longitudinal study
Dino Muslimović1, Bart Post, Johannes D Speelman
1Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. dinomuslimovic@hotmail.com
Summary
Parkinson's disease (PD) patients experience significant cognitive decline within years of diagnosis, impacting attention and psychomotor speed. Predictors of decline differ between newly diagnosed and established PD patients.
Area of Science:
- Neuroscience
- Neurology
- Cognitive Science
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder often associated with cognitive impairment.
- Understanding the trajectory and predictors of cognitive decline is crucial for managing PD progression.
Purpose of the Study:
- To investigate the longitudinal changes in cognitive function in patients with Parkinson's disease.
- To identify factors that predict cognitive decline in both newly diagnosed and established PD patients.
Main Methods:
- A controlled prospective study involving newly diagnosed PD patients, established PD (EPD) patients, and healthy controls.
- Repeated neuropsychological assessments over approximately 3 years using standardized regression-based methods and normative comparisons.
- Analysis of baseline features to predict cognitive changes over time.
Main Results:
- Newly diagnosed PD patients showed significant cognitive decline, particularly in psychomotor speed and attention, over 3 years.
- Approximately 50% of PD patients exhibited cognitive decline, with 9% developing dementia; similar trends were seen in EPD patients.
- In established PD, age at onset and axial impairment predicted cognitive decline, while no baseline predictors were found for newly diagnosed patients.
Conclusions:
- Parkinson's disease patients exhibit a faster rate of cognitive decline compared to healthy individuals shortly after diagnosis.
- Cognitive decline in PD primarily affects attention and psychomotor speed, with memory, visuospatial, and executive functions also impacted.
- Predictors of cognitive decline vary based on disease duration, highlighting the need for tailored monitoring and interventions in PD care.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...